Henrik Franzyk
Associate Professor
henrik.franzyk@sund.ku.dk
Cancer and Infectious Diseases
Through interdisciplinary collaborations, the cluster aims at discovery and optimization of multidrug resistant anticancer and/or antimicrobial lead compounds and validate these by in vitro and in vivo models. Our mission is to:
- Design peptides and peptidomimetics that targets multidrug-resistant bacterial infections
- Identify and validate novel anti-cancer compounds and targets
- Develop and apply cutting-edge technologies for identification of plant and fungal natural products with potential as chemotherapeutic leads
The aim and vision of the Research Cluster can be found here
Cluster leader
Core members
Associate professor Peptide-based Drug Research Group |
Professor Björkling Group |
Associate professor Molecular Disease Biology Group |
Assistant professor Bioanalytical Chemistry and Metabolomics Group |
Associate professor Drug Transporters Group |
Associate professor Peptide-based Drug Research Group |
- Dan Stærk, Professor, Bioanalytical Chemistry and Metabolomics Group
- Jens Soelberg, Senior curator, Peptides & Proteins
- John Nielsen,Professor, Specialised Metabolites Group
- José Moreira, Professor MSO, Molecular & Cellular Pharmacology
- Lennart Bunch, Associate professor, Bunch Research Group
- Matthias Herth, Associate professor, Herth Group